Stericycle, Inc. (SRCL)

$61.98

Market is closed - opens 8 PM, 14 Nov 2024

Highlights

Market Capitalization
5.8B
Book Value
$27.53
Earnings Per Share (EPS)
0.39
PE Ratio
158.92
PEG Ratio
1.58
Wall Street Target Price
61.43
Profit Margin
0.77%
Operating Margin TTM
6.76%
Return On Assets TTM
2.3%
Return On Equity TTM
0.8%
Revenue TTM
2.6B
Revenue Per Share TTM
28.38
Quarterly Revenue Growth YOY
-0.8%
Gross Profit TTM
1.0B
EBITDA
411.1M
Diluted Eps TTM
0.39
Quarterly Earnings Growth YOY
0.17
EPS Estimate Current Year
2.27
EPS Estimate Next Year
2.79
EPS Estimate Current Quarter
0.55
EPS Estimate Next Quarter
0.58

Analyst Recommendation

Buy
    53%Buy
    46%Hold
    0
    0%Sell
Based on 13 Wall street analysts offering stock ratings for Stericycle, Inc.(by analysts ranked 0 to 5 stars)
Based on 13 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
2
Hold
6
6
6
Sell
00
00
5

Analyst Forecast

What analysts predicted

Downside of 0.34%

Current $61.98
Target $61.77

Company Financials

FY18Y/Y Change
Revenue
3.5B
↓ 2.65%
Net Income
-244.7M
↓ 677.12%
Net Profit Margin
-7.02%
↓ 8.2%
FY19Y/Y Change
Revenue
3.3B
↓ 5.08%
Net Income
-346.0M
↑ 41.4%
Net Profit Margin
-10.46%
↓ 3.44%
FY20Y/Y Change
Revenue
2.7B
↓ 19.14%
Net Income
-55.9M
↓ 83.84%
Net Profit Margin
-2.09%
↑ 8.37%
FY21Y/Y Change
Revenue
2.6B
↓ 1.07%
Net Income
-26.8M
↓ 52.06%
Net Profit Margin
-1.01%
↑ 1.08%
FY22Y/Y Change
Revenue
2.7B
↑ 2.18%
Net Income
56.0M
↓ 308.96%
Net Profit Margin
2.07%
↑ 3.08%
FY23Y/Y Change
Revenue
2.7B
↓ 1.68%
Net Income
-21.4M
↓ 138.21%
Net Profit Margin
-0.8%
↓ 2.87%
Q1 FY23Q/Q Change
Revenue
684.3M
↑ 2.07%
Net Income
11.2M
↓ 64.78%
Net Profit Margin
1.64%
↓ 3.1%
Q2 FY23Q/Q Change
Revenue
669.5M
↓ 2.16%
Net Income
-49.5M
↓ 541.96%
Net Profit Margin
-7.39%
↓ 9.03%
Q3 FY23Q/Q Change
Revenue
653.5M
↓ 2.39%
Net Income
2.0M
↓ 104.04%
Net Profit Margin
0.31%
↑ 7.7%
Q4 FY23Q/Q Change
Revenue
652.0M
↓ 0.23%
Net Income
14.9M
↑ 645.0%
Net Profit Margin
2.29%
↑ 1.98%
Q1 FY24Q/Q Change
Revenue
664.9M
↑ 1.98%
Net Income
13.1M
↓ 12.08%
Net Profit Margin
1.97%
↓ 0.32%
Q2 FY24Q/Q Change
Revenue
661.6M
↓ 0.5%
Net Income
6.0M
↓ 54.2%
Net Profit Margin
0.91%
↓ 1.06%
FY18Y/Y Change
Total Assets
6.5B
↓ 7.62%
Total Liabilities
3.9B
↓ 5.42%
FY19Y/Y Change
Total Assets
6.4B
↓ 0.29%
Total Liabilities
4.1B
↑ 6.32%
FY20Y/Y Change
Total Assets
5.6B
↓ 13.28%
Total Liabilities
3.1B
↓ 23.27%
FY21Y/Y Change
Total Assets
5.5B
↓ 1.95%
Total Liabilities
3.1B
↓ 2.45%
FY22Y/Y Change
Total Assets
5.3B
↓ 2.54%
Total Liabilities
2.9B
↓ 5.23%
FY23Y/Y Change
Total Assets
5.4B
↑ 0.35%
Total Liabilities
2.8B
↓ 2.75%
Q1 FY23Q/Q Change
Total Assets
5.3B
↓ 0.04%
Total Liabilities
2.9B
↓ 0.81%
Q2 FY23Q/Q Change
Total Assets
5.2B
↓ 2.23%
Total Liabilities
2.7B
↓ 5.4%
Q3 FY23Q/Q Change
Total Assets
5.2B
↑ 0.63%
Total Liabilities
2.8B
↑ 1.45%
Q4 FY23Q/Q Change
Total Assets
5.4B
↑ 2.03%
Total Liabilities
2.8B
↑ 2.16%
Q1 FY24Q/Q Change
Total Assets
5.4B
↑ 1.55%
Total Liabilities
2.9B
↑ 2.93%
Q2 FY24Q/Q Change
Total Assets
5.5B
↑ 0.76%
Total Liabilities
2.9B
↑ 1.09%
FY18Y/Y Change
Operating Cash Flow
165.7M
↓ 67.42%
Investing Cash Flow
-147.5M
↓ 23.58%
Financing Cash Flow
-25.7M
↓ 92.0%
FY19Y/Y Change
Operating Cash Flow
248.0M
↑ 49.67%
Investing Cash Flow
-104.0M
↓ 29.49%
Financing Cash Flow
-141.6M
↑ 450.97%
FY20Y/Y Change
Operating Cash Flow
530.2M
↑ 113.79%
Investing Cash Flow
381.4M
↓ 466.73%
Financing Cash Flow
-892.5M
↑ 530.3%
FY21Y/Y Change
Operating Cash Flow
303.1M
↓ 42.83%
Investing Cash Flow
-90.1M
↓ 123.62%
Financing Cash Flow
-207.9M
↓ 76.71%
FY22Y/Y Change
Operating Cash Flow
200.2M
↓ 33.95%
Investing Cash Flow
-84.6M
↓ 6.1%
Financing Cash Flow
-110.7M
↓ 46.75%
Q1 FY23Q/Q Change
Operating Cash Flow
49.5M
↓ 68.49%
Investing Cash Flow
-34.5M
↓ 282.54%
Financing Cash Flow
-11.6M
↓ 93.08%
Q2 FY23Q/Q Change
Operating Cash Flow
105.4M
↑ 112.93%
Investing Cash Flow
60.9M
↓ 276.52%
Financing Cash Flow
-196.3M
↑ 1592.24%

Technicals Summary

Sell

Neutral

Buy

Stericycle, Inc. is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin

Institutional Holdings

  • Vanguard Group Inc

    9.62%
  • BlackRock Inc

    8.37%
  • Capital Research Global Investors

    6.00%
  • Clarkston Capital Partners, LLC

    5.69%
  • Black Creek Investment Management Inc

    4.00%
  • Impax Asset Management Group PLC

    3.15%

Company Information

stericycle is a global services company. we provide highly specialized solutions serving healthcare organizations and commercial businesses of every size and shape. throughout the last 25 years, we have grown from a small start-up in medical waste management into a leader across a range of increasingly complex and highly regulated arenas, such as: • brand protection solutions • environmental & sustainable solutions • patient & customer communication solutions • regulated waste management & compliance solutions from the start we have challenged the status quo of what a business solution can be. by identifying unmet needs, we have redefined and transformed multiple industries from a narrowly defined service category to a robust suite of solutions that customers need and want. our success with this strategy has landed stericycle among the fortune 1000 list and forbes 25 most innovative companies. a publicly-traded company with $2.5 billion in 2014 revenue, our core purpose is to

Organization
Stericycle, Inc.
Employees
13095
CEO
Ms. Cindy J. Miller
Industry
Health Services

FAQs